Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma.
Kataoka J, Shiraha H, Horiguchi S, Sawahara H, Uchida D, Nagahara T, Iwamuro M, Morimoto H, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Takaki A, Nouso K, Yagi T, Yamamoto K, Okada H. Kataoka J, et al. Among authors: kuwaki k. Oncol Rep. 2016 May;35(5):2576-82. doi: 10.3892/or.2016.4681. Epub 2016 Mar 16. Oncol Rep. 2016. PMID: 26985715 Free PMC article.
Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis.
Nakanishi Y, Shiraha H, Nishina S, Tanaka S, Matsubara M, Horiguchi S, Iwamuro M, Takaoka N, Uemura M, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yagi T, Yamamoto K. Nakanishi Y, et al. Among authors: kuwaki k. BMC Cancer. 2011 Jan 4;11:3. doi: 10.1186/1471-2407-11-3. BMC Cancer. 2011. PMID: 21205319 Free PMC article.
Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
Tanaka S, Shiraha H, Nakanishi Y, Nishina S, Matsubara M, Horiguchi S, Takaoka N, Iwamuro M, Kataoka J, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Nouso K, Yagi T, Yamamoto K. Tanaka S, et al. Among authors: kuwaki k. Int J Cancer. 2012 Dec 1;131(11):2537-46. doi: 10.1002/ijc.27575. Epub 2012 Apr 24. Int J Cancer. 2012. PMID: 22488108 Free article.
Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
Sawahara H, Shiraha H, Uchida D, Kato H, Kato R, Oyama A, Nagahara T, Iwamuro M, Horiguchi S, Tsutsumi K, Mandai M, Mimura T, Wada N, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Watanabe M, Sakaguchi M, Takaki A, Nouso K, Yagi T, Nasu Y, Kumon H, Okada H. Sawahara H, et al. Among authors: kuwaki k. J Gastroenterol Hepatol. 2017 Oct;32(10):1769-1777. doi: 10.1111/jgh.13757. J Gastroenterol Hepatol. 2017. PMID: 28168749
[Corrigendum] Loss of Runt‑related transcription factor 3 induces resistance to 5‑fluorouracil and cisplatin in hepatocellular carcinoma.
Kataoka J, Shiraha H, Horiguchi S, Sawahara H, Uchida D, Nagahara T, Iwamuro M, Morimoto H, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Takaki A, Nouso K, Yagi T, Yamamoto K, Okada H. Kataoka J, et al. Among authors: kuwaki k. Oncol Rep. 2017 Mar;37(3):1921. doi: 10.3892/or.2017.5419. Epub 2017 Feb 3. Oncol Rep. 2017. PMID: 28184917 Free PMC article.
Hepatocellular carcinoma occurring in hepatobiliary fibropolycystic disease.
Kinugasa H, Nouso K, Kobayashi Y, Yasunaka T, Onishi H, Nakamura S, Shiraha H, Takayama H, Toshimori J, Kuwaki K, Hagihara H, Miyake Y, Ikeda F, Takaki A, Kobashi H, Yamamoto K. Kinugasa H, et al. Among authors: kuwaki k. Hepatol Res. 2011 Mar;41(3):277-81. doi: 10.1111/j.1872-034X.2010.00761.x. Hepatol Res. 2011. PMID: 21338456
Prognostic model for hepatocellular carcinoma with time-dependent factors.
Kuwaki K, Nouso K, Kobayashi Y, Nakamura S, Ito YM, Iwadou S, Hagihara H, Yasunaka T, Toshimori J, Miyatake H, Miyoshi K, Onishi H, Miyake Y, Shoji B, Takaki A, Shiraha H, Iwasaki Y, Kobashi H, Yamamoto K. Kuwaki K, et al. Acta Med Okayama. 2011 Feb;65(1):11-9. doi: 10.18926/AMO/43825. Acta Med Okayama. 2011. PMID: 21339791 Free article.
Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
Nouso K, Kobayashi Y, Nakamura S, Kobayashi S, Takayama H, Toshimori J, Kuwaki K, Hagihara H, Onishi H, Miyake Y, Ikeda F, Shiraha H, Takaki A, Iwasaki Y, Kobashi H, Yamamoto K. Nouso K, et al. Among authors: kuwaki k. J Gastroenterol Hepatol. 2011 Jul;26(7):1195-200. doi: 10.1111/j.1440-1746.2011.06720.x. J Gastroenterol Hepatol. 2011. PMID: 21410750
188 results